Greenville Health System Institutional Review Board — Greenville, South Carolina

Greenville Health System Institutional Review Board is a clinical research site located in Greenville, South Carolina, United States 29615.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Greenville Health System Institutional Review Board has participated in 1 clinical trials.

Therapeutic areas: Diffuse Large B-cell Lymphoma Refractory, Follicular B-cell Non-Hodgkin's Lymphoma.

Sponsors: Seagen Inc..

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Greenville Health System Institutional Review Board?

Greenville Health System Institutional Review Board has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Greenville Health System Institutional Review Board conducted?

Greenville Health System Institutional Review Board has 1 clinical trials on record. Their work covers Diffuse Large B-cell Lymphoma Refractory, Follicular B-cell Non-Hodgkin's Lymphoma.

Is Greenville Health System Institutional Review Board accredited by Crixeo Health?

Greenville Health System Institutional Review Board has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Greenville Health System Institutional Review Board?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.